Execution-only platforms, such as Hargreaves Lansdown's Vantage, could be subject to the same disclosure terms as those platforms conducting adviser business, the FSA says.
While most industry respondents to the FSA platform paper believe changes to platform remuneration should also apply to non-advised business, the FSA says it will not ban payments from product providers to platforms in this channel. However, the FSA it is desirable for there to be common standards for advised and non-advised business "wherever possible", which includes disclosure. The FSA plans to publish a separate consultation paper on how platforms should disclose their charging structures, including fund manager rebates, on top of its second consultation document in February. "...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes